Literature DB >> 9464278

Molecular cloning and mapping of human semaphorin F from the Cri-du-chat candidate interval.

A D Simmons1, A W Püschel, J D McPherson, J Overhauser, M Lovett.   

Abstract

Cri-du-chat is a human contiguous gene deletion syndrome resulting from hemizygous deletions of chromosome 5p. Here we describe the isolation from within this interval of the human Semaphorin F (SEMAF) gene, a member of a family of proteins that has been implicated in axonal pathfinding. The human SEMAF gene covers at least 10% of the deleted region and defines a new class within this large gene family characterized by the presence of seven type 1 thrombospondin repeats. Prominent expression of murine semaphorin F (Semaf) was observed in the mouse brain, consistent with a role for semaphorin F as a signaling molecule that guides axons or migrating neuronal precursors during development. The known functions of semaphorins and the interesting pattern of expression for Semaf suggest that haploinsufficiency for SEMAF may disrupt normal brain development and might lead to some of the features of Cri-du-chat.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464278     DOI: 10.1006/bbrc.1997.8027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Gene expression profile following stable expression of the cellular prion protein.

Authors:  Jun-ichi Satoh; Takashi Yamamura
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

Review 2.  Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer.

Authors:  Abhilasha Purohit; Anguraj Sadanandam; Pavan Myneni; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2014-09-28

3.  A balanced t(10;15) translocation in a male patient with developmental language disorder.

Authors:  A Gulhan Ercan-Sencicek; Nicole R Davis Wright; Stephan J Sanders; Nicole Oakman; Lianna Valdes; Betul Bakkaloglu; Niamh Doyle; Carolyn M Yrigollen; Thomas M Morgan; Elena L Grigorenko
Journal:  Eur J Med Genet       Date:  2011-12-29       Impact factor: 2.708

4.  High-resolution whole-genome association study of Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Timothy G Lesnick; Kari J Strain; Matthew J Farrer; Walter A Rocca; P V Krishna Pant; Kelly A Frazer; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

5.  Constitutional downregulation of SEMA5A expression in autism.

Authors:  M Melin; B Carlsson; H Anckarsater; M Rastam; C Betancur; A Isaksson; C Gillberg; N Dahl
Journal:  Neuropsychobiology       Date:  2006-10-05       Impact factor: 2.328

6.  Cloning, expression, and genetic mapping of Sema W, a member of the semaphorin family.

Authors:  J A Encinas; K Kikuchi; A Chedotal; F de Castro; C S Goodman; T Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  The early developmental gene Semaphorin 5c contributes to olfactory behavior in adult Drosophila.

Authors:  Stephanie M Rollmann; Akihiko Yamamoto; Tim Goossens; Liesbeth Zwarts; Zsuzsanna Callaerts-Végh; Patrick Callaerts; Koenraad Norga; Trudy F C Mackay; Robert R H Anholt
Journal:  Genetics       Date:  2007-04-15       Impact factor: 4.562

Review 8.  5p deletions: Current knowledge and future directions.

Authors:  Joanne M Nguyen; Krista J Qualmann; Rebecca Okashah; AmySue Reilly; Mikhail F Alexeyev; Dennis J Campbell
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-08-03       Impact factor: 3.908

9.  Plexin-B3 is a functional receptor for semaphorin 5A.

Authors:  Stefania Artigiani; Paolo Conrotto; Pietro Fazzari; Giorgio F Gilestro; Davide Barberis; Silvia Giordano; Paolo M Comoglio; Luca Tamagnone
Journal:  EMBO Rep       Date:  2004-06-25       Impact factor: 8.807

Review 10.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.

Authors:  Ling Lin; Timothy G Lesnick; Demetrius M Maraganore; Ole Isacson
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.